Superinfection immunity is found in the conjugal transfer of R factors between two fi+ R factors and between two ft-R factors (fi = fertility inhibition), as we reported previously. In contrast, no whereas fi+ and fi-R factors have not been observed to recombine after superinfection by conjugation (19). The possible recombination between two fi-R factors has not yet been studied, because fi-R factors with suitable drug-resistance markers have not been available.
R factors or transmissible drug-resistance factors (12) can be classified into two types, fi+ andfi-, depending on the presence or absence of fertility-inhibition or suppression of the fertility of the sex factor F of Escherichia coli K-12 (19) . The mechanism of fertility-inhibition by fi+ R factors has been found to be the result of an inhibition of F pilus formation (7, 8) . The rate of conjugal transfer of an R factor is reduced by the presence in the recipient strain of an R factor of the same fi type as that of the donor strain (19) . This repression of superinfection with R factors was referred to as superinfection immunity. We previously presented an hypothesis on the mechanism of superinfection immunity as follows (19) . R factors may replicate at specific sites on the inner side of the cell surface, and these sites may be different for fi+ and fi-R factors. There may be a limitation of sites, so that two different R factors of the same fi type compete with each other for occupation of a replication site. Thus, one of the two R factors may fail to occupy a replication site and, being unable to replicate, segregate at high frequency at cell division. Thus, the mechanism of superinfection immunity may be the phenomenon of "mutual exclusion." We have also shown that two different fi+ R factors in the same cells recombine genetically at high frequencies, whereas fi+ and fi-R factors have not been observed to recombine after superinfection by conjugation (19) . The possible recombination between two fi-R factors has not yet been studied, because fi-R factors with suitable drug-resistance markers have not been available.
We recently studied the transduction of R factors, by phage Plkc in E. coli and by phage P22 in Salmonella typhimurium, to recipients already carrying R factors, that is, R factor superinfection by transduction. We found no detectable immunity to superinfection in the transduction in these two systems. The frequency of transduction of an fi+ R factor was somewhat reduced by the presence of any of several fi-R factors in the recipient. Furthermore, fi+ and fr R factors. The R factors employed are listed in Table 1 .
Culture media. Liquid cultures were prepared in Penassay Broth (Difco). Nutrient Agar (Difco) and bromothymol blue-lactose-nutrient agar media (containing 2% lactose) were employed as solid media.
Procedure for conjugal transfer of R factors. The procedure for the conjugal transfer of R factors was described previously (13, 15) .
Procedures for transduction of R factors. The procedures for transduction of R factors in E. coli by phage Plkc and in S. typhimurium by phage P22 were described in a previous paper (16) .
RESULTS
Transduction of the fi+ R factor 222 by phage Plkc to E. coli CSH-2 recipients carrying various R factors. Phage Plkc was grown on E. coli CSH-2 harboring an fi+ R factor, 222, carrying the markers of resistance to sulfanilamide (SU), streptomycin (SM), chloramphenicol (CM), and tetracycline (TC), and was used for transduction. The R factors in the recipient CSH-2 lacked some of the drug-resistance markers of the R factor 222, and the transductants were selected by the drugs to which the recipient strains were sensitive. There was no reduction in the frequency of transduction of 222 by the presence of any fi+ R factor in the recipient (Table 2 ). In contrast, the presence of any of three different Jl-R factors in the recipient caused appreciable reduction in the transduction frequency of 222.
Transduction of an fi+ R factor, 222, by phage P22 to S. typhimurium LT-2 recipients carrying various R factors. Phage P22 was propagated on S. typhimurium LT-2 harboring R factor 222 a CSH-2 is a methionine-requiring, F-substrain of K-12. The procedure for transduction was the same as described previously (16) . and used for transduction. Since the drugresistance markers of 222 are invariably segregated into TC and the other three markers during transduction by P22, and the frequencies of transduction of the TC marker are very low (16) , only the CM-resistant transductants were studied by using LT-2 recipients carrying various R factors lacking the CM-resistance marker (Table  3) . Results similar to those obtained with phage Plkc in E. coli were found; there was no reduction in the frequency of transduction of the drug-resistance markers of 222 by the presence of fi+ R factors in the recipient, whereas the transduction of 222 markers was reduced to some extent by the presence of fi-JR factors in the recipient.
Conjugal transmissibility of superinjfected R factors. A majority of the drug-resistant transductants obtained by the transduction of R factor 222 with phage P22 in S. typhimurium LT-2 cannot transfer their drug-resistance markers by conjugation (16) . However, when the strain used as a P22 transductional recipient already carried an R factor fi+ or fi-, the transduced CM marker was found to be transmissible by conjugation, along with the drug-resistance markers of the resident R factor. Kinetic studies on the conjugal transfer of the drug-resistance markers have shown that none of the CMresistant transductants obtained by phage P22 are capable of transferring the CM-resistance marker independently of the drug-resistance markers of the recipient R factor. The proportion of the CM-resistant transductants capable of conjugal transfer of the CM marker, together with the TC marker of the recipient R factor, varied considerably (18 to 62%) among R fac- tors present in the recipient (Table 3 ). There was no correlation between these frequencies and the fi type of the R factors in the recipient.
Since the transduced CM marker was always transferred concomitantly with the R factor already present in the recipient, it was suspected that the transduced R factor (defective) had recombined physically with the R factor in the recipient. To test this possibility, we attempted to transduce the drug-resistance markers of the suspected recombinant R factors. One possible recombinant factor was first transmitted from S. typhimurium LT-2 to E. coli CSH-2, then used as a donor for further transduction with phage PI kc. The CM and TC markers of "recombinant" factor N-3 .CM5 could be cotransduced at rather high frequencies, whereas the CM and TC markers of "recombinant" factor N-9 CM48 were cotransduced at only low frequencies ( Table 4) . The CM and TC markers of N-iICM2 could not be transduced at detectable frequencies. It is inferred that "recombinant" R factors N-3 -CM5 and N-9 -CM48 are transduced as functional units by phage Plkc in view of the linked transduction of the four drug-resistance markers and the determinant of their conjugal transferability. It coli, a "deletion" mutant 222-R3, isolated from R factor 222 in S. typhimurium LT-2 (18), was used as a donor R factor, because this mutant lacks the TC marker and is convenient for studying its recombination with the TC markercarrying R factors. In this case, also, no superinfection immunity was observed in the transduction of 222-R3 to recipients carrying various R factors, fi+ or fi- (Table 5 ). Reduction in the frequencies of transduction of 222-R3 was again found, although slightly, in the recipients carrying fl-R factors in this experiment. The transduced CM marker of some (8 to 50%) of the transductants could be transferred by conjugation together with the R factors of the recipient.
Transduction of the drug-resistance markers of these possible recombinant factors by phage Plkc in E. coli CSH-2 was attempted. One of each of the suspected recombinant factors derived from the various R factors was used as a transductional donor R factor. The frequencies of transduction of the CM and TC markers were very low, except in N-3-CM48 ( N-1-CM2 <2.0 X 10-t1 <2.0 X 10-n N-3-CM5 8.4 X 10-6 SU, SM, CM, TC, t+ 50/50 5.8 X 10-7 SU, SM, CM, TC, t+ 36/75 SU, SM, TC, t+ 39/75 N-6-CM46 4.4 X 10-Il SU, SM, CM, t-1/1 <3.3 X 10-11 N-9-CM48 5.3 X 10-10 SU, SM, CM, TC, t+ 3/3 <1.5 X 10-'1 a CSH-2 is a methionine-requiring, F-substrain of K-12.
b "Recombinant" R factors were obtained by phage P22 transduction of an fi+ R factor 222 (SU, SM, CM, TC) to S. typhimurium LT-2 carrying various R factors in the experiments shown in Table 3 . All of these "recombinant" R factors had the markers of resistance to SU, SM, CM, and TC, and their conjugal transferability.
c Presence and absence of conjugal transferability are indicated by t+ and t-, respectively. The procedure for transduction was the same as described previously (16). N-1. a CSH-2 is a methionine-requiring, F-substrain of K-12.
b "Recombinant" R factors were obtained by transduction with phage Plkc of anfi+ R factor 222-R3
(SU, SM, CM) to E. coli CSH-2 carrying various R factors in the experiments shown in Table 5 . All of these "recombinant" R factors had the markers of resistance to SU, SM, CM, and TC, of which at least the CM marker must have been derived from the 222-R3 factor of the donor. c Presence of conjugal transferability is indicated by t+. The procedure for transduction was the same as described previously (16) . fer were determined after mixed incubation of donor and recipient for 60 min at 37 C, following the procedure described previously (13, 15) .
the host-controlled restrictions are as a rule exerted in common against various kinds of deoxyribonucleic acids (1). Phage Plkc was therefore propagated on E. coli CSH-2 carrying two R factors, 222-R3 (fi+) and N-3 (fi-). N-3 is a restricting and modifying R factor (19) . We have already shown that 222-R3 and N-3 do not exclude each other or recombine genetically when they are brought together by conjugal superinfection (19) . In fact, the CM marker of 222-R3 and the TC marker of N-3 cannot be cotransduced by Plkc. The CM marker of 222-R3
was then transduced by Plkc to CSH-2 with and without f-R factor N-3 or R-15. N-3 and R-15 are known to cause the same host-controlled modification of phages (19) . It was found ( Table  9 ) that the frequencies of transduction of the CM marker by Plkc, propagated on the donor strain carrying both 222-R3 and N-3, were not reduced in the recipient carrying N-3 or R-15, unlike the results in Table 2 . These results suggest that R factor 222-R3 probably undergoes hostcontrolled modification in the cells carrying N-3.
DIscussioN
We have reported above three findings. First, no superinfection immunity is observed in the transduction of an fi+ R factor to the recipients carrying either fi+ or fl-R factors. Secondly, the transduction of the fi+ R factor 222 is reduced, although only slightly, by the presence of ft-R factors in the recipients. Thirdly, the transduced fi+ R factor 222 recombines with the R factors in the recipients at high frequencies, regardless of their fi types.
The first point, that is, the absence of superinfection immunity in the transduction of R factors, seems to offer an important clue to the elucidation of the mechanisms of immunity to conjugal superinfection by R factors and nonviral episomes in general. We have shown that the fi+ R factor 222 transduced by Plkc does not show any hereditary peculiarity in superinfection immunity character; i.e., it has the same ability to exclude, and susceptibility to exclusion, as R factor 222 which has not been transduced. It is obvious that the R factors carried by trans-1800 ducing phage particles enter recipient cells through phage-specific receptor sites. The conjugal transfer of fi+ R factors is assumed from the work of Brinton, Gemski, and Carnahan (4) and Brinton (3) to take place through F pili (14) . It has been shown thatfl-R factors induce the formation of specific pili different from F pili (6, 9) . We assume that the specific pili may bind to specific pilus receptor sites on the surface of the recipient bacteria (14) . (19) . However, with the evidence presented here, it appears that mutual exclusion does not play a major role in superinfection immunity. The mechanism of superinfection immunity of R and F factors will be discussed in detail in a later paper, on the basis of these as well as further findings.
The second point, namely, the reduction in the frequencies of transduction of R factor 222 by the presence of fi-R factors in the recipients, can be accounted for by a host-controlled restriction of the transduced fi+ R factor by the /i-R factors in the recipients, because the f-R factors are known to cause host-controlled restriction and modification of phages (2, 19, 20) and also because R factors were shown to be composed of deoxyribonucleic acid (5, 11) . In fact, we have shown that phage Plkc transducing an fi+ R factor 222-Rs is modified by the presence of an fi-R factor N-3 in the same cells, so that its transfer is no longer restricted by N-3 present in the recipient. It is not surprising to find that R factors are sensitive to host-controlled restriction and modification, since we have already shown that R factors can be restricted and modified in S. typhimurium (10) .
The third point, the frequent recombination with various R factors (fi+ and fl-) of the fi+ R factor 222 when transduced by phage Plkc in E. coli or by phage P22 in S. typhimurium, is particularly interesting in view of the finding that recombination does not easily take place between fi+ and ft-R factors in the superinfection by conjugation (19) .
In transduction with P22, the frequent recombination might be accounted for by the selective advantage of the recombinants, since nonrecombinant factors will result in abortive transduction unless they are integrated into host chromosome with the help of the transducing phage genome, as the drug-resistance markers cannot be cotransduced with resistance transfer factor (12) . By contrast, the results with phage Plkc cannot be explained in a similar fashion, since R factor 222 can usually be transduced as a unit (including resistance transfer factor) by Plkc, and the recombinants should have no selective advantage over nonrecombinants.
We do not know yet the reason for the frequent recombination of the transduced 222 with the recipient R factors. As already mentioned, R factor 222 transduced by Plkc has no hereditary peculiarity with regard to its superinfection immunity, but there still remains a possibility that R factor 222 transduced by Plkc has some temporary difference from the original R factor, for example, the association with Plkc genome that may be lost during replication of the R factor in the recipient cells.
There seem to be various types of recombinants between the transduced 222 and the recipient R factors as shown by the results of transduction by Plkc. The recombinants with N-3 gave rather high frequencies of cotransduction of the drug-resistance markers of both the parent R factors; the other recombinants gave only infrequent or no cotransduction of their drug-resistance markers. This point requires further investigation.
We have already shown that ft-R factors can also be transduced by phage Plkc in E. coli and by phage P22 in S. typhimurium (17) . We are currently studying the transduction of fi-R factors to recipients carrying various R factors, fi+ and f/-. The results of this study will be reported in a separate paper.
